Sean Brynjelsen Biography and Net Worth

Sean E. Brynjelsen serves as President, Chief Executive Officer, Director of the Company. He has held multiple senior management positions in the pharmaceutical industry over the last 25 years. Prior to joining Eton, Mr. Brynjelsen served as Corporate Officer and Executive Vice President, Business Development, at Sagent Pharmaceuticals, Inc., where he made a number of successful transactions, and the company ultimately was acquired by Nichi-Iko Pharmaceuticals Co., Ltd. for $736MM. Prior to his tenure at Sagent, he was Senior Vice President, Global Business Development for Akorn and executed numerous product and M&A transactions. The company had a market cap of approximately $3 billion when he left the company in 2016 and revenues had increased from $70MM to over $1.1B during his tenure. Earlier in his career, Mr. Brynjelsen spent a number of years in product development focused on sterile pharmaceuticals at both Baxter and Pfizer (formerly Hospira). Mr. Brynjelsen is also a named inventor on several U.S. patents in the fields of drug delivery and formulation science. Mr. Brynjelsen earned an MBA degree from the University of Notre Dame and holds a Master of Science in Chemistry and a Bachelor of Science in Biochemistry from the University of Illinois.

What is Sean Brynjelsen's net worth?: The estimated net worth of Sean Brynjelsen is at least $3.27 million as of September 22nd, 2022. Mr. Brynjelsen owns 1,040,000 shares of Eton Pharmaceuticals stock worth more than $3,265,600 as of April 17th. This net worth estimate does not reflect any other assets that Mr. Brynjelsen may own. Additionally, Mr. Brynjelsen receives a salary of $868,130.00 as CEO at Eton Pharmaceuticals. Learn More about Sean Brynjelsen's net worth.
How old is Sean Brynjelsen?: Mr. Brynjelsen is currently 52 years old. There are 1 older executives and no younger executives at Eton Pharmaceuticals. Learn More on Sean Brynjelsen's age.
What is Sean Brynjelsen's salary?: As the CEO of Eton Pharmaceuticals, Inc., Mr. Brynjelsen earns $868,130.00 per year. Learn More on Sean Brynjelsen's salary.
How do I contact Sean Brynjelsen?: The corporate mailing address for Mr. Brynjelsen and other Eton Pharmaceuticals executives is 21925 W. FIELD PARKWAY SUITE 235, DEER PARK IL, 60010. Eton Pharmaceuticals can also be reached via phone at (847) 787-7361 and via email at [email protected]. Learn More on Sean Brynjelsen's contact information.
Has Sean Brynjelsen been buying or selling shares of Eton Pharmaceuticals?: Sean Brynjelsen has not been actively trading shares of Eton Pharmaceuticals over the course of the past ninety days. Most recently, on Thursday, September 22nd, Sean Brynjelsen bought 10,000 shares of Eton Pharmaceuticals stock. The stock was acquired at an average cost of $2.10 per share, with a total value of $21,000.00. Following the completion of the transaction, the chief executive officer now directly owns 1,040,000 shares of the company's stock, valued at $2,184,000. Learn More on Sean Brynjelsen's trading history.

Sean Brynjelsen Insider Trading History at Eton Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/22/2022	Buy	10,000	$2.10	$21,000.00	1,040,000
6/3/2021	Buy	5,000	$5.96	$29,800.00	1,030,000
8/13/2019	Buy	5,000	$6.15	$30,750.00
5/21/2019	Buy	10,000	$7.93	$79,300.00
11/15/2018	Buy	10,000	$6.00	$60,000.00

Sean Brynjelsen Buying and Selling Activity at Eton Pharmaceuticals

Eton Pharmaceuticals Company Overview

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Today's Range

Now: $3.14

$3.03

$3.20

50 Day Range

MA: $4.06

$3.19

$4.59

2 Week Range

Now: $3.14

$2.42

$5.81

Volume

86,718 shs

Average Volume

69,317 shs

Market Capitalization

$80.67 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.17

Options trading has suddenly become more reliable.

From Eagle Publishing | Ad

When it hits at a stunning 96% win rate... Options trading has suddenly become more reliable.

Click here to see how simple option trades win 96% of the time.